EGFR-Mutated NSCLC: Treatment Options Following Progression on Osimertinib
Ticiana Leal, MD, gives a comprehensive overview of treatment options for patients with EGFR-mutated NSCLC who progress on osimertinib therapy.
Source: onclive.com
Page 43 - Nsclc News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nsclc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nsclc Today - Breaking & Trending Today
Neoadjuvant Therapy in Early NSCLC Treatment
A panel discusses the role of neoadjuvant therapy in the current treatment approach for early stages of NSCLC.
Source: ajmc.com
Chemoimmunotherapy Timing: Pre or Post Surgery for Patients With NSCLC
Experts deliberate on the optimal timing of chemoimmunotherapy and if it should be before or after surgery.
Source: ajmc.com
FDA OKs Neoadjuvant/Adjuvant Pembrolizumab in NSCLC
The approval allows for continuous immunotherapy treatment around surgery for resectable non-small cell lung cancer.
Source: medscape.com
Genentech: Alecensa Reduces Risk Of Disease Recurrence/ Death In ALK-Positive Early-Stage NSCLC
Genentech, Inc., affiliated to Swiss drug major Roche Holding AG (RHHBY), announced Wednesday results from the primary analysis of the Phase III ALINA study of Alecensa (alectinib) in people with anaplastic lymphoma kinase or ALK-positive non-small cell lung cancer or NSCLC.
Source: rttnews.com